<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="27226">Uric acid</z:chebi> is a major <z:chebi fb="11" ids="22586">antioxidant</z:chebi> in the blood of humans that can protect cultured neurons against oxidative and metabolic insults </plain></SENT>
<SENT sid="1" pm="."><plain>However, <z:chebi fb="3" ids="27226">uric acid</z:chebi> has a very low solubility which compromises its potential clinical use for <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we describe the synthesis, characterization and preclinical development of neuroprotective <z:chebi fb="36" ids="29309">methyl</z:chebi>- and <z:chebi fb="0" ids="26833">sulfur</z:chebi>-containing analogs of <z:chebi fb="3" ids="27226">uric acid</z:chebi> with increased solubility </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro and cell culture screening identified 1,7-dimethyluric acid (mUA2) and 6,8-dithiouric acid (sUA2) as two analogs with high <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and neuroprotective activities </plain></SENT>
<SENT sid="4" pm="."><plain>When administered intravenously in mice, <z:chebi fb="3" ids="27226">uric acid</z:chebi> analogs mUA2 and sUA2 lessened damage to the brain and improved functional outcome in an <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion mouse model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Analogs sUA2 and mUA2 were also effective in reducing damage to the cerebral cortex when administered up to 4 h after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> in a permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> mouse model </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest a therapeutic potential for soluble analogs of <z:chebi fb="3" ids="27226">uric acid</z:chebi> in the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> and related neurodegenerative conditions </plain></SENT>
</text></document>